Legato Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Buy
+32,190
New +$1.35M 0.16% 196
2024
Q1
Sell
-44,218
Closed -$1.22M 617
2023
Q4
$1.22M Hold
44,218
0.16% 214
2023
Q3
$987K Sell
44,218
-2,095
-5% -$53.9K 0.14% 245
2023
Q2
$1.18M Buy
46,313
+12,352
+36% +$299K 0.16% 212
2023
Q1
$757K Buy
33,961
+8,297
+32% +$201K 0.14% 254
2022
Q4
$609K Buy
+25,664
New +$596K 0.12% 287

Other funds holding VCYT

Legato Capital Management's VCYT Position: Q2 2026 in Review

Legato Capital Management opened a new position in Veracyte (VCYT) in Q2 2026: 32,190 shares worth $1.89M. The stake represents 0.16% of the portfolio and ranks #196 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in VCYT as recently as Q4 2023.

Legato Capital Management first reported a position in VCYT in Q4 2022 and has held it in 6 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Legato Capital Management held 32,190 shares of Veracyte worth $1.89M as of Q2 2026.
  • Veracyte was a new Legato Capital Management position in Q2 2026.
  • Veracyte made up 0.16% of Legato Capital Management's portfolio in Q2 2026, its #196 holding.
  • Legato Capital Management first reported a position in Veracyte in Q4 2022 and has held it in 6 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.